| Identification | Back Directory | [Name]
4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide | [CAS]
506417-09-0 | [Synonyms]
GPR41 agonist-1
4-{3-nitrophenyl}-2-methyl-N-(2-methylphenyl)-5-oxo-1,4,5,6,7,8-hexahydro-3-quinolinecarboxamide | [Molecular Formula]
C24H23N3O4 | [MOL File]
506417-09-0.mol | [Molecular Weight]
417.457 |
| Hazard Information | Back Directory | [Uses]
GPR41 agonist-1 (compound 9) is a potent GPR41 agonist. GPR41 agonist-1 can be used for researching insulin-related disorders[1]. | [References]
[1] James N. Leonard, et al. Gpr41 and modulators thereof for the treatment of insulin-related disorders. WO2006052566A2. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
| Company Name: |
Specs
|
| Tel: |
+31 15 251 8111 |
| Website: |
www.specs.net |
|